Zolpidem for persistent insomnia in SSRI-treated depressed patients.

  title={Zolpidem for persistent insomnia in SSRI-treated depressed patients.},
  author={Gregory M. Asnis and A Chakraburtty and E A Duboff and A. D. Krystal and Peter D Londborg and Russell Rosenberg and Barbara F Roth-Schechter and Martin B. Scharf and James K Walsh},
  journal={The Journal of clinical psychiatry},
  volume={60 10},
BACKGROUND Depressed individuals effectively treated with selective serotonin reuptake inhibitors (SSRIs) often report persistent insomnia and require adjunctive sleep-promoting therapy. METHOD Men (N = 40) and women (N = 150) with a mean age of 41.6 years who had persistent insomnia in the presence of effective and stable treatment (at least 2 weeks) with fluoxetine (< or =40 mg/day), sertraline (< or =100 mg/day), or paroxetine (< or =40 mg/day) for DSM-IV major depressive disorder… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 43 extracted citations

Similar Papers

Loading similar papers…